Overview

Clarithromycin Susceptibility-Guided Treatment of Helicobacter Pylori Infection

Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
0
Participant gender:
All
Summary
The aim of this study is to assess the safety and efficacy of clarithromycin susceptibility-guided therapy as the first line treatment for H pylori infection compared with empirical bismuth-containing quadruple therapy.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Liaocheng People's Hospital
Treatments:
Amoxicillin
Bismuth
Clarithromycin
Fluoroquinolones
Criteria
Inclusion Criteria:

- patients for first-line treatment of Helicobacter pylori infection

Exclusion Criteria:

- penicillin allergy

- pregnancy and lactation